VIDEO: Allergan official discusses Vuity, business acquisitions

ByJag Dosanjh

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS —In this Healio Video Perspective from the Eyecelerator meeting, Jag Dosanjh, senior vice president of U.S. eye care for Allergan, discusses activity within the company.

Dosanjh touches on recent acquisitions and the FDA approval of Vuity (pilocarpine HCl ophthalmic solution 1.25%).

Published by:

Sources/Disclosures

Collapse

Source: Jag Dosanjh

Read more about

ophthalmic business

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment